Woodland International Research Group, Inc

What Woodland International Research Group, Inc does

Woodland International Research Group, Inc operates a Phase I-IV clinical research site in Little Rock, Arkansas, as part of the Evolution Research Group (ERG) network of 11 wholly-owned clinical research facilities spanning six U.S. states (AR, CA, FL, OH, NY, TX). The facility specializes in trials for psychiatric disorders, pain, Alzheimer's disease, hepatic and renal impairment, and other debilitating conditions, alongside healthy-volunteer studies. Recruitment of trial participants is conducted through direct facility contact, the corporate website, social channels (Facebook, Twitter), educational blog content, community health screening events, and the proprietary MyTrial App (Version 2), which integrates patient notifications, Uber-based transportation coordination, refer-a-friend functionality, and study schedule management.

The core product is contract clinical trial execution for pharmaceutical and biotech sponsors across multiple therapeutic areas, with the parent ERG network positioning itself as one of the largest clinical research organizations in the U.S. Sponsors engage Woodland through professional-services contracts for study conduct, patient enrollment, and data collection, while trial participants receive study-specific compensation for time and travel. Underlying technical and operational assets include the MyTrial App V2 platform, GCP/ICH-trained study coordinators, board-certified psychiatrists and psychologists, and the cross-site infrastructure shared across ERG's 11 facilities.

The company is privately held with no disclosed VC, PE, or institutional investor backing. No acquisitions, funding rounds, leadership changes, or partnership transactions are disclosed in the available information. Ownership structure, financials, and management team details are not publicly available, limiting visibility into capital structure, governance, and growth investment capacity. Marketing and patient outreach are community-led, relying on local presence in Little Rock and surrounding Arkansas communities, free health screening events, and digital engagement channels to build volunteer pipelines for sponsor studies.

Name

Woodland International Research Group, Inc

Legal name

Evolution Research Group

Website

https://woodlandintlresearchgrp.com

Company type

Private

Operating status

Operating

Short description

Woodland International Research Group operates a Phase I-IV clinical trial site in Little Rock, Arkansas, as part of Evolution Research Group's 11-facility network. It conducts trials in psychiatric, pain, Alzheimer's, hepatic, renal, and healthy-volunteer indications for pharmaceutical and biotech sponsors across six U.S. states.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH), Liver & GI Clinical Research (Trials Centers) (HLAKAEAL), Rare Neurology & Neurodegenerative Disorder Therapies (HLAIAIAD)

Keywords

• Clinical trial services
• Clinical research network
• Clinical pharmacology research
• Psychiatric disorder trials
• Phase I-IV clinical trials

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Conduct Services: Conducts clinical trials for pharmaceutical and biotech sponsors, receiving compensation for study execution, patient enrollment, and data collection services. Revenue is generated through contractual agreements with drug developers for Phase I-IV clinical research across multiple therapeutic areas.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Woodland International Research Group conducts Phase I-IV clinical trials for pharmaceutical and biotech sponsors at its Little Rock, Arkansas facility, specializing in studies for healthy volunteers and patients with psychiatric disorders, pain, Alzheimer's disease, hepatic and renal impairment, and other debilitating conditions. As part of the Evolution Research Group network, the facility supports participant recruitment, study execution, and data collection using GCP/ICH-compliant procedures and the MyTrial App mobile platform.

Product overview

Woodland International Research Group, Inc operates as part of the Evolution Research Group (ERG) network of clinical research facilities. The company offers clinical trial services for multiple therapeutic areas including psychiatric disorders, pain, Alzheimer's disease, hepatic/renal conditions, and other debilitating diseases. As part of the ERG network, it has access to the MyTrial App mobile platform for participant management, which includes features such as patient notifications, Uber integration for transportation coordination, referral functionality, and schedule management. The network comprises multiple research facilities across multiple states including Arkansas, California, Florida, Ohio, New York, and Texas.

Differentiator

Problem solved

Functional benefit

Brands

• MyTrial App: Mobile application for managing study participation with features including patient notifications, Uber integration, refer-a-friend, and schedule management

Products and services

• MyTrial App A mobile application for managing clinical trial participation, enabling study volunteers to receive notifications, manage schedules, coordinate transportation via Uber integration, and refer friends to studies. Available on Google Play and App Store. Used by clinical trial participants across the Evolution Research Group network.
• Clinical Research Services Phase I-IV clinical trial conduct services for healthy volunteers and patients with psychiatric disorders, pain, Alzheimer's disease, hepatic and renal impairment, and other debilitating conditions. Provided to pharmaceutical and biotech sponsors under contractual agreements covering study execution, patient enrollment, and data collection. The facility is part of the Evolution Research Group network located in Little Rock, Arkansas.

Quantifiable outcome

• Rigorous GCP/ICH compliant clinical trial conduct ensuring top-tier data quality and volunteer subject safety

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Direct peers

• Velocity Clinical Research: One of the largest U.S. dedicated clinical research site networks, with comparable multi-state site footprint and therapeutic breadth. Operates a similar sponsor-facing model of running Phase I–IV trials across multiple therapeutic areas for pharma/biotech clients.
• Cenexel Research Network: Multi-site clinical research organization with deep CNS, hepatic and pain therapeutic focus — directly overlapping with ERG's specialty areas. Comparable business model of wholly-owned research sites delivering Phase I–IV trial conduct to pharmaceutical sponsors.
• Altasciences: Integrated early-phase CRO with extensive clinical pharmacology unit (CPU) capacity. Comparable to ERG's Clinical Pharmacology of Miami offering and similar positioning around hepatic/renal impairment and CNS Phase I trials.
• Accel Research Sites: U.S. multi-site clinical research network running Phase I–IV trials across therapeutic areas including CNS and metabolic indications. Operates a similar site-network business model serving pharma/biotech sponsors.
• Compass Research: Independent U.S. clinical research site network conducting Phase I–IV trials across multiple therapeutic areas for pharmaceutical sponsors. Operates a similar site-based model and competes for the same community-recruited patient populations.

Broad incumbents

• Medpace: Mid-sized global CRO with established clinical trial management capabilities and a significant site network. Competes with ERG for sponsor contracts but operates a much broader full-service CRO model that includes site management as one component.
• IQVIA: Largest global CRO with dedicated site management solutions (including Accellacare, the former Synexus SMO network). Competes with ERG by offering integrated site services at global scale alongside broader CRO/biopharma services.
• ICON plc: Global CRO (post-PRA Health Sciences merger) with substantial site relationships across multiple therapeutic areas. Competes with ERG for large multi-region pivotal trials and offers embedded site solutions to sponsors.
• Worldwide Clinical Trials: Mid-tier global CRO with particularly strong CNS, pain and rare disease franchises. Direct therapeutic-area overlap with ERG and competing for the same sponsor neuroscience study placements.

Emerging players

• Collaborative Neuroscience Network: Smaller specialty SMO focused on CNS and neuroscience clinical trials. Comparable therapeutic focus to ERG's psychiatric/Alzheimer's sites, but with a more limited geographic footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/midwestclinical
• Facebookfacebook.com/MidwestClinicalResearchCenter

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Woodland International Research Group, Inc